

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.31777937 |
| 2 | barbed-end actin filament capping (GO:0051016) | 3.21046350 |
| 3 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.14794415 |
| 4 | alpha-linolenic acid metabolic process (GO:0036109) | 3.09935956 |
| 5 | valine metabolic process (GO:0006573) | 2.97354806 |
| 6 | regulation of ARF protein signal transduction (GO:0032012) | 2.93264574 |
| 7 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.90124089 |
| 8 | positive regulation of histone deacetylation (GO:0031065) | 2.83343930 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.81710627 |
| 10 | negative regulation of cell killing (GO:0031342) | 2.81710627 |
| 11 | positive regulation of fatty acid oxidation (GO:0046321) | 2.81561357 |
| 12 | growth hormone receptor signaling pathway (GO:0060396) | 2.80251263 |
| 13 | response to laminar fluid shear stress (GO:0034616) | 2.79143396 |
| 14 | surfactant homeostasis (GO:0043129) | 2.78941955 |
| 15 | semaphorin-plexin signaling pathway (GO:0071526) | 2.76031858 |
| 16 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.75683483 |
| 17 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.71176874 |
| 18 | negative regulation of cell size (GO:0045792) | 2.70287886 |
| 19 | regulation of triglyceride catabolic process (GO:0010896) | 2.62752595 |
| 20 | protein carboxylation (GO:0018214) | 2.61876454 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.61876454 |
| 22 | adherens junction assembly (GO:0034333) | 2.61772758 |
| 23 | apoptotic cell clearance (GO:0043277) | 2.61212854 |
| 24 | protein targeting to plasma membrane (GO:0072661) | 2.60969258 |
| 25 | L-phenylalanine catabolic process (GO:0006559) | 2.60637925 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.60637925 |
| 27 | regulation of early endosome to late endosome transport (GO:2000641) | 2.59983124 |
| 28 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.59424762 |
| 29 | regulation of ARF GTPase activity (GO:0032312) | 2.59241352 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.57920530 |
| 31 | positive regulation of receptor recycling (GO:0001921) | 2.56588559 |
| 32 | complement activation, alternative pathway (GO:0006957) | 2.55136650 |
| 33 | cell-cell junction maintenance (GO:0045217) | 2.53352684 |
| 34 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.52315377 |
| 35 | mannose metabolic process (GO:0006013) | 2.52087737 |
| 36 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.51433148 |
| 37 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.50610021 |
| 38 | stress fiber assembly (GO:0043149) | 2.49711193 |
| 39 | modulation by symbiont of host cellular process (GO:0044068) | 2.48848926 |
| 40 | lymph vessel development (GO:0001945) | 2.47337558 |
| 41 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.46828750 |
| 42 | transcytosis (GO:0045056) | 2.46686567 |
| 43 | cellular response to growth hormone stimulus (GO:0071378) | 2.46585172 |
| 44 | regulation of extracellular matrix organization (GO:1903053) | 2.45123147 |
| 45 | cell-substrate adherens junction assembly (GO:0007045) | 2.44187636 |
| 46 | focal adhesion assembly (GO:0048041) | 2.44187636 |
| 47 | fatty acid beta-oxidation (GO:0006635) | 2.44038780 |
| 48 | protein heterotrimerization (GO:0070208) | 2.43179764 |
| 49 | fatty acid transmembrane transport (GO:1902001) | 2.42228226 |
| 50 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.41634987 |
| 51 | modulation by virus of host process (GO:0019054) | 2.41297605 |
| 52 | activation of JUN kinase activity (GO:0007257) | 2.41075423 |
| 53 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.40422810 |
| 54 | positive regulation of extracellular matrix organization (GO:1903055) | 2.39715788 |
| 55 | apoptotic process involved in morphogenesis (GO:0060561) | 2.37446177 |
| 56 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.37305417 |
| 57 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.37019524 |
| 58 | negative regulation of lipase activity (GO:0060192) | 2.36306668 |
| 59 | cell migration involved in heart development (GO:0060973) | 2.35724230 |
| 60 | L-phenylalanine metabolic process (GO:0006558) | 2.34438591 |
| 61 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.34438591 |
| 62 | regulation of extracellular matrix disassembly (GO:0010715) | 2.33296315 |
| 63 | protein retention in ER lumen (GO:0006621) | 2.32476702 |
| 64 | virion attachment to host cell (GO:0019062) | 2.32390564 |
| 65 | adhesion of symbiont to host cell (GO:0044650) | 2.32390564 |
| 66 | regulation of fatty acid oxidation (GO:0046320) | 2.32044039 |
| 67 | maternal placenta development (GO:0001893) | 2.31642707 |
| 68 | fatty acid oxidation (GO:0019395) | 2.31141812 |
| 69 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.30767146 |
| 70 | hemidesmosome assembly (GO:0031581) | 2.30567614 |
| 71 | lipid oxidation (GO:0034440) | 2.28194185 |
| 72 | adhesion of symbiont to host (GO:0044406) | 2.27789914 |
| 73 | regulation of cholesterol homeostasis (GO:2000188) | 2.26738625 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.26654755 |
| 75 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.26396597 |
| 76 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.26328868 |
| 77 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.26114425 |
| 78 | sulfur amino acid catabolic process (GO:0000098) | 2.26049165 |
| 79 | positive regulation of protein dephosphorylation (GO:0035307) | 2.25742837 |
| 80 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.25563240 |
| 81 | positive regulation of glycogen metabolic process (GO:0070875) | 2.24636901 |
| 82 | thymic T cell selection (GO:0045061) | 2.24625051 |
| 83 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.24203075 |
| 84 | response to fluid shear stress (GO:0034405) | 2.23810839 |
| 85 | ethanol oxidation (GO:0006069) | 2.23582445 |
| 86 | regulation of sequestering of triglyceride (GO:0010889) | 2.23324421 |
| 87 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.23272875 |
| 88 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.23263687 |
| 89 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.23263687 |
| 90 | fibril organization (GO:0097435) | 2.22025678 |
| 91 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.21723741 |
| 92 | regulation of lipid kinase activity (GO:0043550) | 2.19914591 |
| 93 | modulation by symbiont of host immune response (GO:0052553) | 2.18412544 |
| 94 | positive regulation by symbiont of host defense response (GO:0052509) | 2.18412544 |
| 95 | modulation by symbiont of host defense response (GO:0052031) | 2.18412544 |
| 96 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.18412544 |
| 97 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.18412544 |
| 98 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.18412544 |
| 99 | cortical actin cytoskeleton organization (GO:0030866) | 2.18371803 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 2.18282899 |
| 101 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.18080261 |
| 102 | carnitine shuttle (GO:0006853) | 2.17931502 |
| 103 | glomerular basement membrane development (GO:0032836) | 2.17775181 |
| 104 | regulation of cholesterol storage (GO:0010885) | 2.16618193 |
| 105 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 2.16250603 |
| 106 | activation of MAPKKK activity (GO:0000185) | 2.15765991 |
| 107 | cell-substrate junction assembly (GO:0007044) | 2.15597748 |
| 108 | positive regulation of Rap GTPase activity (GO:0032854) | 2.15514940 |
| 109 | negative regulation of granulocyte differentiation (GO:0030853) | 2.15319024 |
| 110 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.14928488 |
| 111 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.14235936 |
| 112 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.13944837 |
| 113 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.13613797 |
| 114 | fatty acid catabolic process (GO:0009062) | 2.13581649 |
| 115 | short-chain fatty acid metabolic process (GO:0046459) | 2.13576149 |
| 116 | negative regulation of fibrinolysis (GO:0051918) | 2.13386786 |
| 117 | gland morphogenesis (GO:0022612) | 2.12800299 |
| 118 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.12617414 |
| 119 | extracellular fibril organization (GO:0043206) | 2.12047391 |
| 120 | regulation of triglyceride metabolic process (GO:0090207) | 2.11888296 |
| 121 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.11846181 |
| 122 | regulation of leukocyte degranulation (GO:0043300) | 2.11013372 |
| 123 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.10744425 |
| 124 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.09329066 |
| 125 | regulation of response to osmotic stress (GO:0047484) | 2.09269374 |
| 126 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.09243479 |
| 127 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.09041068 |
| 128 | cerebellar granule cell differentiation (GO:0021707) | 2.08829034 |
| 129 | positive regulation of cholesterol efflux (GO:0010875) | 2.08741442 |
| 130 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.08455362 |
| 131 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.08453896 |
| 132 | positive regulation of cholesterol transport (GO:0032376) | 2.08446970 |
| 133 | positive regulation of sterol transport (GO:0032373) | 2.08446970 |
| 134 | chemical homeostasis within a tissue (GO:0048875) | 2.06632195 |
| 135 | endothelial cell chemotaxis (GO:0035767) | 2.06590342 |
| 136 | response to muramyl dipeptide (GO:0032495) | 2.06025979 |
| 137 | signal complex assembly (GO:0007172) | 2.05912802 |
| 138 | cell volume homeostasis (GO:0006884) | 2.05512078 |
| 139 | monocarboxylic acid catabolic process (GO:0072329) | 2.05038447 |
| 140 | regulation of macrophage cytokine production (GO:0010935) | 2.04778324 |
| 141 | regulation of fibrinolysis (GO:0051917) | 2.04571801 |
| 142 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.04507273 |
| 143 | low-density lipoprotein particle clearance (GO:0034383) | 2.04295314 |
| 144 | Rho protein signal transduction (GO:0007266) | 2.03900811 |
| 145 | modulation by virus of host morphology or physiology (GO:0019048) | 2.03679079 |
| 146 | negative regulation of fatty acid transport (GO:2000192) | 2.03590511 |
| 147 | regulation of protein activation cascade (GO:2000257) | 2.03525450 |
| 148 | negative regulation of protein autophosphorylation (GO:0031953) | 2.03355694 |
| 149 | basement membrane organization (GO:0071711) | 2.03160795 |
| 150 | negative regulation of myotube differentiation (GO:0010832) | 2.02726695 |
| 151 | triglyceride catabolic process (GO:0019433) | 2.02715844 |
| 152 | regulation of p38MAPK cascade (GO:1900744) | 2.02655340 |
| 153 | negative regulation of glial cell proliferation (GO:0060253) | 2.02494442 |
| 154 | hormone catabolic process (GO:0042447) | 2.02400785 |
| 155 | regulation of complement activation (GO:0030449) | 2.01951523 |
| 156 | acylglycerol catabolic process (GO:0046464) | 2.01914337 |
| 157 | neutral lipid catabolic process (GO:0046461) | 2.01914337 |
| 158 | venous blood vessel morphogenesis (GO:0048845) | 2.01592760 |
| 159 | lysine metabolic process (GO:0006553) | 2.01465564 |
| 160 | lysine catabolic process (GO:0006554) | 2.01465564 |
| 161 | atrioventricular valve morphogenesis (GO:0003181) | 2.00941184 |
| 162 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.00392068 |
| 163 | intracellular lipid transport (GO:0032365) | 2.00287389 |
| 164 | embryo implantation (GO:0007566) | 1.99927572 |
| 165 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 1.99880019 |
| 166 | positive regulation of lipid kinase activity (GO:0090218) | 1.99769310 |
| 167 | phospholipid homeostasis (GO:0055091) | 1.99256863 |
| 168 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 1.99120055 |
| 169 | positive thymic T cell selection (GO:0045059) | 1.99107596 |
| 170 | 2-oxoglutarate metabolic process (GO:0006103) | 1.98773485 |
| 171 | protein localization to endosome (GO:0036010) | 1.98567619 |
| 172 | phospholipid efflux (GO:0033700) | 1.98039110 |
| 173 | collagen fibril organization (GO:0030199) | 1.97089589 |
| 174 | desmosome organization (GO:0002934) | 1.96070345 |
| 175 | glomerular visceral epithelial cell development (GO:0072015) | 1.94811736 |
| 176 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 1.94674779 |
| 177 | epoxygenase P450 pathway (GO:0019373) | 1.94549363 |
| 178 | regulation of cholesterol biosynthetic process (GO:0045540) | 1.93982351 |
| 179 | coronary vasculature morphogenesis (GO:0060977) | 1.93891818 |
| 180 | skin morphogenesis (GO:0043589) | 1.93817662 |
| 181 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 1.93792607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.40462604 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.24004451 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68025279 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.59934639 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.53320398 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.38257934 |
| 7 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.33249440 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.22166176 |
| 9 | * TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.21226124 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.14953317 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.12558320 |
| 12 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.11975934 |
| 13 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03097806 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.01647417 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.91976964 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.90700660 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 1.87998462 |
| 18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.80508227 |
| 19 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.77114589 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76475027 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76387175 |
| 22 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.76080877 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.75633129 |
| 24 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.73036417 |
| 25 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.72777076 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.71244844 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.66923271 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66161490 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.63577142 |
| 30 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.61061271 |
| 31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58856885 |
| 32 | P68_20966046_ChIP-Seq_HELA_Human | 1.56858023 |
| 33 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.54402411 |
| 34 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.53632637 |
| 35 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.52881746 |
| 36 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.52437511 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50940415 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.50536053 |
| 39 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.49685736 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45579108 |
| 41 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.45552963 |
| 42 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.43275446 |
| 43 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.43275446 |
| 44 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42327361 |
| 45 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.41697318 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41110929 |
| 47 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.40984525 |
| 48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39436530 |
| 49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38721471 |
| 50 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36139300 |
| 51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35843401 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35065586 |
| 53 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33415952 |
| 54 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.32716621 |
| 55 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.31548455 |
| 56 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.30522134 |
| 57 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.28717025 |
| 58 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.27891674 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.26989347 |
| 60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26134140 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24889706 |
| 62 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23656607 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22582859 |
| 64 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22316821 |
| 65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22180145 |
| 66 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.22130344 |
| 67 | KDM2B_26808549_Chip-Seq_K562_Human | 1.20975944 |
| 68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20945416 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20890185 |
| 70 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.20848969 |
| 71 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20350695 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.19803323 |
| 73 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19377997 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18872891 |
| 75 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18017101 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17905583 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17799809 |
| 78 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.15652682 |
| 79 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15311799 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15245284 |
| 81 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14672811 |
| 82 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14669207 |
| 83 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13943150 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13715004 |
| 85 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.13481620 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12797590 |
| 87 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.12601245 |
| 88 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.11069023 |
| 89 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.11069023 |
| 90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11044733 |
| 91 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10835254 |
| 92 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09687781 |
| 93 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08360878 |
| 94 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.07684225 |
| 95 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07684087 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07679000 |
| 97 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.07518597 |
| 98 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.06837538 |
| 99 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06565838 |
| 100 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06404157 |
| 101 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.06268518 |
| 102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05053507 |
| 103 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03875480 |
| 104 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.03806646 |
| 105 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.03585236 |
| 106 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03233581 |
| 107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02549819 |
| 108 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.02441088 |
| 109 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.02133258 |
| 110 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01850537 |
| 111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01786247 |
| 112 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.01648056 |
| 113 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00498825 |
| 114 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99915068 |
| 115 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99422387 |
| 116 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99380847 |
| 117 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98733474 |
| 118 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98344884 |
| 119 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98282278 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97621641 |
| 121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97393521 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97393521 |
| 123 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97340521 |
| 124 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97244520 |
| 125 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97120827 |
| 126 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96609514 |
| 127 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96439214 |
| 128 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95978023 |
| 129 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.95585367 |
| 130 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95400554 |
| 131 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95332250 |
| 132 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.95300066 |
| 133 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94384837 |
| 134 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93863052 |
| 135 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93376076 |
| 136 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92151766 |
| 137 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.91874218 |
| 138 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.90590010 |
| 139 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89993744 |
| 140 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.89905428 |
| 141 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89765519 |
| 142 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89688018 |
| 143 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.89276480 |
| 144 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88518280 |
| 145 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88159246 |
| 146 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.87724265 |
| 147 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.87461956 |
| 148 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87227526 |
| 149 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.85583413 |
| 150 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.85041853 |
| 151 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.84355787 |
| 152 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.83522798 |
| 153 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.83167216 |
| 154 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.82711767 |
| 155 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82300889 |
| 156 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82261215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.61638674 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 2.91042244 |
| 3 | MP0005275_abnormal_skin_tensile | 2.62128973 |
| 4 | MP0005365_abnormal_bile_salt | 2.56471691 |
| 5 | MP0004858_abnormal_nervous_system | 2.55274099 |
| 6 | MP0010368_abnormal_lymphatic_system | 2.44138049 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.38257891 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.37203493 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.34409037 |
| 10 | MP0005409_darkened_coat_color | 2.25376846 |
| 11 | MP0003303_peritoneal_inflammation | 2.23791279 |
| 12 | MP0001879_abnormal_lymphatic_vessel | 2.17509529 |
| 13 | MP0004272_abnormal_basement_membrane | 2.15818605 |
| 14 | MP0003436_decreased_susceptibility_to | 2.14427796 |
| 15 | MP0005670_abnormal_white_adipose | 2.11578801 |
| 16 | MP0004130_abnormal_muscle_cell | 2.10064963 |
| 17 | MP0009384_cardiac_valve_regurgitation | 2.09988706 |
| 18 | MP0003252_abnormal_bile_duct | 2.09694879 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.09217652 |
| 20 | MP0005360_urolithiasis | 2.04977942 |
| 21 | MP0003045_fibrosis | 2.01444613 |
| 22 | MP0005451_abnormal_body_composition | 1.99073568 |
| 23 | MP0008260_abnormal_autophagy | 1.98559570 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.97214917 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.92554419 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.87768721 |
| 27 | MP0004185_abnormal_adipocyte_glucose | 1.84409764 |
| 28 | MP0003329_amyloid_beta_deposits | 1.83589881 |
| 29 | MP0001958_emphysema | 1.78166135 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.76679020 |
| 31 | MP0002254_reproductive_system_inflammat | 1.75514853 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.72924649 |
| 33 | MP0001348_abnormal_lacrimal_gland | 1.72887231 |
| 34 | MP0002249_abnormal_larynx_morphology | 1.72323401 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.67952407 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 1.67229871 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.66150559 |
| 38 | MP0009278_abnormal_bone_marrow | 1.66117462 |
| 39 | MP0003724_increased_susceptibility_to | 1.65417208 |
| 40 | MP0002060_abnormal_skin_morphology | 1.63892909 |
| 41 | MP0003091_abnormal_cell_migration | 1.61067897 |
| 42 | MP0003279_aneurysm | 1.60233005 |
| 43 | MP0002837_dystrophic_cardiac_calcinosis | 1.55305420 |
| 44 | MP0004859_abnormal_synaptic_plasticity | 1.54408257 |
| 45 | MP0005375_adipose_tissue_phenotype | 1.53711832 |
| 46 | MP0005503_abnormal_tendon_morphology | 1.52398070 |
| 47 | MP0005085_abnormal_gallbladder_physiolo | 1.46973672 |
| 48 | MP0004510_myositis | 1.44641898 |
| 49 | MP0005076_abnormal_cell_differentiation | 1.43203927 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.38973494 |
| 51 | MP0001666_abnormal_nutrient_absorption | 1.37657605 |
| 52 | MP0000003_abnormal_adipose_tissue | 1.34916420 |
| 53 | MP0003879_abnormal_hair_cell | 1.34387730 |
| 54 | MP0004084_abnormal_cardiac_muscle | 1.34354776 |
| 55 | MP0002118_abnormal_lipid_homeostasis | 1.34250228 |
| 56 | MP0006082_CNS_inflammation | 1.32646650 |
| 57 | MP0008875_abnormal_xenobiotic_pharmacok | 1.32139551 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.30617014 |
| 59 | MP0000604_amyloidosis | 1.28496029 |
| 60 | MP0006054_spinal_hemorrhage | 1.21433060 |
| 61 | MP0009643_abnormal_urine_homeostasis | 1.19942784 |
| 62 | MP0002909_abnormal_adrenal_gland | 1.19827507 |
| 63 | MP0002896_abnormal_bone_mineralization | 1.19371692 |
| 64 | MP0002168_other_aberrant_phenotype | 1.17514171 |
| 65 | MP0003690_abnormal_glial_cell | 1.16843276 |
| 66 | MP0004036_abnormal_muscle_relaxation | 1.16648806 |
| 67 | MP0000678_abnormal_parathyroid_gland | 1.16390306 |
| 68 | MP0000681_abnormal_thyroid_gland | 1.14629779 |
| 69 | MP0000733_abnormal_muscle_development | 1.13988709 |
| 70 | MP0005390_skeleton_phenotype | 1.13264813 |
| 71 | MP0000858_altered_metastatic_potential | 1.11432882 |
| 72 | MP0005257_abnormal_intraocular_pressure | 1.10692414 |
| 73 | MP0000609_abnormal_liver_physiology | 1.10002661 |
| 74 | MP0002009_preneoplasia | 1.09962813 |
| 75 | MP0003566_abnormal_cell_adhesion | 1.09757051 |
| 76 | MP0000767_abnormal_smooth_muscle | 1.08199673 |
| 77 | MP0009840_abnormal_foam_cell | 1.07583250 |
| 78 | MP0002295_abnormal_pulmonary_circulatio | 1.05960438 |
| 79 | MP0002796_impaired_skin_barrier | 1.04734390 |
| 80 | MP0001756_abnormal_urination | 1.04227320 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.04083023 |
| 82 | MP0002138_abnormal_hepatobiliary_system | 1.00697549 |
| 83 | MP0001873_stomach_inflammation | 1.00212555 |
| 84 | MP0002419_abnormal_innate_immunity | 0.99330421 |
| 85 | MP0005623_abnormal_meninges_morphology | 0.98611172 |
| 86 | MP0001270_distended_abdomen | 0.98409454 |
| 87 | MP0003634_abnormal_glial_cell | 0.97794828 |
| 88 | MP0001849_ear_inflammation | 0.97468406 |
| 89 | MP0005332_abnormal_amino_acid | 0.97314394 |
| 90 | MP0005025_abnormal_response_to | 0.97078002 |
| 91 | MP0002971_abnormal_brown_adipose | 0.96365320 |
| 92 | MP0002089_abnormal_postnatal_growth/wei | 0.96304201 |
| 93 | MP0002006_tumorigenesis | 0.95639649 |
| 94 | MP0005595_abnormal_vascular_smooth | 0.92717809 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 0.92673852 |
| 96 | MP0000465_gastrointestinal_hemorrhage | 0.92337773 |
| 97 | MP0005166_decreased_susceptibility_to | 0.91490477 |
| 98 | MP0001533_abnormal_skeleton_physiology | 0.89550150 |
| 99 | MP0006138_congestive_heart_failure | 0.89473478 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.89380834 |
| 101 | MP0010155_abnormal_intestine_physiology | 0.88516558 |
| 102 | MP0000751_myopathy | 0.87607688 |
| 103 | MP0001851_eye_inflammation | 0.86918843 |
| 104 | MP0003195_calcinosis | 0.86079602 |
| 105 | MP0009379_abnormal_foot_pigmentation | 0.83443143 |
| 106 | MP0001765_abnormal_ion_homeostasis | 0.83309533 |
| 107 | MP0000759_abnormal_skeletal_muscle | 0.83078499 |
| 108 | MP0005334_abnormal_fat_pad | 0.82504862 |
| 109 | MP0003075_altered_response_to | 0.82246150 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.81651901 |
| 111 | MP0010030_abnormal_orbit_morphology | 0.80353492 |
| 112 | MP0000920_abnormal_myelination | 0.80335898 |
| 113 | MP0002933_joint_inflammation | 0.80335683 |
| 114 | MP0001944_abnormal_pancreas_morphology | 0.80103021 |
| 115 | MP0009333_abnormal_splenocyte_physiolog | 0.79640559 |
| 116 | MP0009115_abnormal_fat_cell | 0.79552709 |
| 117 | MP0003763_abnormal_thymus_physiology | 0.78356425 |
| 118 | MP0000249_abnormal_blood_vessel | 0.77930150 |
| 119 | MP0002932_abnormal_joint_morphology | 0.77186341 |
| 120 | MP0002108_abnormal_muscle_morphology | 0.76825780 |
| 121 | MP0008569_lethality_at_weaning | 0.76766796 |
| 122 | MP0008874_decreased_physiological_sensi | 0.76138120 |
| 123 | MP0004381_abnormal_hair_follicle | 0.75994962 |
| 124 | MP0005319_abnormal_enzyme/_coenzyme | 0.74736733 |
| 125 | MP0002128_abnormal_blood_circulation | 0.74066672 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.73810763 |
| 127 | MP0001542_abnormal_bone_strength | 0.73803290 |
| 128 | MP0002078_abnormal_glucose_homeostasis | 0.73242608 |
| 129 | MP0010630_abnormal_cardiac_muscle | 0.72811377 |
| 130 | MP0005023_abnormal_wound_healing | 0.71927679 |
| 131 | MP0005083_abnormal_biliary_tract | 0.71836157 |
| 132 | MP0005000_abnormal_immune_tolerance | 0.71677958 |
| 133 | MP0004145_abnormal_muscle_electrophysio | 0.71171627 |
| 134 | MP0003795_abnormal_bone_structure | 0.70495973 |
| 135 | MP0005385_cardiovascular_system_phenoty | 0.70418682 |
| 136 | MP0001544_abnormal_cardiovascular_syste | 0.70418682 |
| 137 | MP0001545_abnormal_hematopoietic_system | 0.70228311 |
| 138 | MP0005397_hematopoietic_system_phenotyp | 0.70228311 |
| 139 | MP0003866_abnormal_defecation | 0.70078004 |
| 140 | MP0001790_abnormal_immune_system | 0.69583346 |
| 141 | MP0005387_immune_system_phenotype | 0.69583346 |
| 142 | MP0005464_abnormal_platelet_physiology | 0.69378411 |
| 143 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68896467 |
| 144 | MP0000343_altered_response_to | 0.67915103 |
| 145 | MP0003828_pulmonary_edema | 0.66821697 |
| 146 | MP0010678_abnormal_skin_adnexa | 0.66632387 |
| 147 | MP0004087_abnormal_muscle_fiber | 0.66508026 |
| 148 | MP0000534_abnormal_ureter_morphology | 0.66481282 |
| 149 | MP0005165_increased_susceptibility_to | 0.65194992 |
| 150 | MP0005508_abnormal_skeleton_morphology | 0.64944013 |
| 151 | MP0001661_extended_life_span | 0.64878854 |
| 152 | MP0004947_skin_inflammation | 0.63976393 |
| 153 | MP0003453_abnormal_keratinocyte_physiol | 0.63886484 |
| 154 | MP0000685_abnormal_immune_system | 0.63529030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Obstructive sleep apnea (HP:0002870) | 4.04923703 |
| 2 | Broad metatarsal (HP:0001783) | 3.52012305 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.40051648 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.31503837 |
| 5 | Cerebral aneurysm (HP:0004944) | 3.19117773 |
| 6 | Aortic dissection (HP:0002647) | 3.18938982 |
| 7 | Complement deficiency (HP:0004431) | 3.11624893 |
| 8 | Aortic aneurysm (HP:0004942) | 3.09804331 |
| 9 | Premature rupture of membranes (HP:0001788) | 2.94270899 |
| 10 | Vertebral compression fractures (HP:0002953) | 2.72863354 |
| 11 | Dysostosis multiplex (HP:0000943) | 2.66287469 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 2.61286393 |
| 13 | Hematochezia (HP:0002573) | 2.59974126 |
| 14 | Atrophic scars (HP:0001075) | 2.54648652 |
| 15 | Xanthomatosis (HP:0000991) | 2.52706829 |
| 16 | Cervical subluxation (HP:0003308) | 2.49648575 |
| 17 | Eczematoid dermatitis (HP:0000976) | 2.46923424 |
| 18 | Mitral valve prolapse (HP:0001634) | 2.46521250 |
| 19 | Broad face (HP:0000283) | 2.46442324 |
| 20 | Hyperacusis (HP:0010780) | 2.45773524 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.44570015 |
| 22 | Mucopolysacchariduria (HP:0008155) | 2.44570015 |
| 23 | Aneurysm (HP:0002617) | 2.40468111 |
| 24 | Shallow orbits (HP:0000586) | 2.39039837 |
| 25 | Abnormality of complement system (HP:0005339) | 2.38928233 |
| 26 | Ankle contracture (HP:0006466) | 2.38723935 |
| 27 | Increased variability in muscle fiber diameter (HP:0003557) | 2.38527190 |
| 28 | Neurofibrillary tangles (HP:0002185) | 2.38408603 |
| 29 | Hypoglycemic coma (HP:0001325) | 2.36941210 |
| 30 | Ketoacidosis (HP:0001993) | 2.32477747 |
| 31 | Arterial tortuosity (HP:0005116) | 2.30664790 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 2.29710776 |
| 33 | Hemorrhage of the eye (HP:0011885) | 2.29468310 |
| 34 | Polycythemia (HP:0001901) | 2.28352597 |
| 35 | Hyperlipoproteinemia (HP:0010980) | 2.26198281 |
| 36 | Vascular tortuosity (HP:0004948) | 2.26156711 |
| 37 | Buphthalmos (HP:0000557) | 2.26149561 |
| 38 | Genu recurvatum (HP:0002816) | 2.25554844 |
| 39 | Ketosis (HP:0001946) | 2.25016421 |
| 40 | Myocardial infarction (HP:0001658) | 2.21438468 |
| 41 | Stridor (HP:0010307) | 2.20119048 |
| 42 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.19716089 |
| 43 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.19716089 |
| 44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.19716089 |
| 45 | Spondylolisthesis (HP:0003302) | 2.16987569 |
| 46 | Mitral stenosis (HP:0001718) | 2.16935428 |
| 47 | Hyporeflexia of lower limbs (HP:0002600) | 2.15031656 |
| 48 | Joint stiffness (HP:0001387) | 2.14525068 |
| 49 | Emphysema (HP:0002097) | 2.14401055 |
| 50 | Abnormality of the intrinsic pathway (HP:0010989) | 2.13655527 |
| 51 | Supranuclear gaze palsy (HP:0000605) | 2.12597585 |
| 52 | Hypercortisolism (HP:0001578) | 2.10760965 |
| 53 | Increased connective tissue (HP:0009025) | 2.10594071 |
| 54 | Biconcave vertebral bodies (HP:0004586) | 2.10178527 |
| 55 | J-shaped sella turcica (HP:0002680) | 2.09906784 |
| 56 | Prolonged partial thromboplastin time (HP:0003645) | 2.09620562 |
| 57 | Peritonitis (HP:0002586) | 2.09339906 |
| 58 | Spontaneous hematomas (HP:0007420) | 2.08404379 |
| 59 | Nephritis (HP:0000123) | 2.08283701 |
| 60 | Thin bony cortex (HP:0002753) | 2.07678191 |
| 61 | Cellulitis (HP:0100658) | 2.07566424 |
| 62 | Distal lower limb muscle weakness (HP:0009053) | 2.07041895 |
| 63 | Cerebral inclusion bodies (HP:0100314) | 2.05231222 |
| 64 | Type 1 muscle fiber predominance (HP:0003803) | 2.05054515 |
| 65 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.03470422 |
| 66 | Lymphangioma (HP:0100764) | 1.99802288 |
| 67 | Long toe (HP:0010511) | 1.99709965 |
| 68 | Mesangial abnormality (HP:0001966) | 1.99078380 |
| 69 | Systemic lupus erythematosus (HP:0002725) | 1.99045906 |
| 70 | Acanthosis nigricans (HP:0000956) | 1.95986310 |
| 71 | Asymmetric septal hypertrophy (HP:0001670) | 1.95958719 |
| 72 | Joint hemorrhage (HP:0005261) | 1.95345306 |
| 73 | Wormian bones (HP:0002645) | 1.94262325 |
| 74 | Atelectasis (HP:0100750) | 1.93060951 |
| 75 | Polygenic inheritance (HP:0010982) | 1.92935025 |
| 76 | Striae distensae (HP:0001065) | 1.91666239 |
| 77 | Annular pancreas (HP:0001734) | 1.91479442 |
| 78 | Ulnar bowing (HP:0003031) | 1.91010017 |
| 79 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.90880284 |
| 80 | Disproportionate tall stature (HP:0001519) | 1.89789273 |
| 81 | Visceral angiomatosis (HP:0100761) | 1.89733722 |
| 82 | Joint laxity (HP:0001388) | 1.88853465 |
| 83 | Amyloidosis (HP:0011034) | 1.88556222 |
| 84 | Distal lower limb amyotrophy (HP:0008944) | 1.87709283 |
| 85 | Bundle branch block (HP:0011710) | 1.87168810 |
| 86 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86903645 |
| 87 | Spinal rigidity (HP:0003306) | 1.86513057 |
| 88 | Hypoplasia of the iris (HP:0007676) | 1.85836039 |
| 89 | Upper limb amyotrophy (HP:0009129) | 1.85745581 |
| 90 | Distal upper limb amyotrophy (HP:0007149) | 1.85745581 |
| 91 | Bladder diverticulum (HP:0000015) | 1.85728063 |
| 92 | Glomerulonephritis (HP:0000099) | 1.85480725 |
| 93 | Follicular hyperkeratosis (HP:0007502) | 1.84856339 |
| 94 | Abnormality of glycolipid metabolism (HP:0010969) | 1.84544351 |
| 95 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.84544351 |
| 96 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.84544351 |
| 97 | Achilles tendon contracture (HP:0001771) | 1.83492051 |
| 98 | Turricephaly (HP:0000262) | 1.83475632 |
| 99 | Axonal loss (HP:0003447) | 1.83198562 |
| 100 | Hyperextensible skin (HP:0000974) | 1.82674447 |
| 101 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.81882755 |
| 102 | Fragile skin (HP:0001030) | 1.81811141 |
| 103 | Gingivitis (HP:0000230) | 1.81083265 |
| 104 | Dilatation of the ascending aorta (HP:0005111) | 1.80764323 |
| 105 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.79815934 |
| 106 | Increased cerebral lipofuscin (HP:0011813) | 1.79698221 |
| 107 | Vacuolated lymphocytes (HP:0001922) | 1.78513810 |
| 108 | Ectopia lentis (HP:0001083) | 1.78463596 |
| 109 | Spinal canal stenosis (HP:0003416) | 1.78251551 |
| 110 | Slender build (HP:0001533) | 1.77347753 |
| 111 | Abnormality of the nasal mucosa (HP:0000433) | 1.77204889 |
| 112 | Back pain (HP:0003418) | 1.77134250 |
| 113 | Mitral regurgitation (HP:0001653) | 1.77034468 |
| 114 | Focal segmental glomerulosclerosis (HP:0000097) | 1.76748070 |
| 115 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.76183199 |
| 116 | Hyperparathyroidism (HP:0000843) | 1.75763496 |
| 117 | Nuclear cataract (HP:0100018) | 1.75244773 |
| 118 | Flat acetabular roof (HP:0003180) | 1.75182279 |
| 119 | Intrahepatic cholestasis (HP:0001406) | 1.75136059 |
| 120 | Increased IgE level (HP:0003212) | 1.74332944 |
| 121 | Nasal polyposis (HP:0100582) | 1.72116463 |
| 122 | Growth hormone excess (HP:0000845) | 1.70693909 |
| 123 | Camptodactyly of toe (HP:0001836) | 1.70493397 |
| 124 | Spinal cord lesions (HP:0100561) | 1.69939311 |
| 125 | Syringomyelia (HP:0003396) | 1.69939311 |
| 126 | Hypoalphalipoproteinemia (HP:0003233) | 1.69736832 |
| 127 | Hemangiomatosis (HP:0007461) | 1.69635738 |
| 128 | Interstitial pulmonary disease (HP:0006530) | 1.69144950 |
| 129 | Hypokalemic alkalosis (HP:0001949) | 1.68994686 |
| 130 | Colitis (HP:0002583) | 1.68137694 |
| 131 | Aortic regurgitation (HP:0001659) | 1.67839249 |
| 132 | Venous abnormality (HP:0002624) | 1.67270994 |
| 133 | Abnormality of the thoracic spine (HP:0100711) | 1.67196602 |
| 134 | Increased CSF protein (HP:0002922) | 1.67022159 |
| 135 | Protuberant abdomen (HP:0001538) | 1.66975128 |
| 136 | Blue sclerae (HP:0000592) | 1.66538784 |
| 137 | Bronchomalacia (HP:0002780) | 1.66273294 |
| 138 | Bone cyst (HP:0012062) | 1.65934706 |
| 139 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.65420281 |
| 140 | Hyperglycinuria (HP:0003108) | 1.65131262 |
| 141 | Congenital glaucoma (HP:0001087) | 1.64109291 |
| 142 | Round ear (HP:0100830) | 1.62812674 |
| 143 | Soft skin (HP:0000977) | 1.62636581 |
| 144 | Nonimmune hydrops fetalis (HP:0001790) | 1.62266503 |
| 145 | Neuronal loss in central nervous system (HP:0002529) | 1.61822994 |
| 146 | Hypertriglyceridemia (HP:0002155) | 1.61552365 |
| 147 | Enlarged penis (HP:0000040) | 1.61145408 |
| 148 | Abnormality of the Achilles tendon (HP:0005109) | 1.60205616 |
| 149 | Generalized aminoaciduria (HP:0002909) | 1.60006176 |
| 150 | Purpura (HP:0000979) | 1.59944028 |
| 151 | Difficulty running (HP:0009046) | 1.59912252 |
| 152 | Facial diplegia (HP:0001349) | 1.59595646 |
| 153 | Cardiovascular calcification (HP:0011915) | 1.58837293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.92847865 |
| 2 | ERN1 | 3.52166158 |
| 3 | PRPF4B | 3.34296308 |
| 4 | TGFBR2 | 2.98356461 |
| 5 | SIK1 | 2.51406589 |
| 6 | TIE1 | 2.16569503 |
| 7 | SMG1 | 2.08354778 |
| 8 | PKN2 | 2.03960235 |
| 9 | RIPK1 | 1.94174866 |
| 10 | ICK | 1.86441227 |
| 11 | INSRR | 1.82023188 |
| 12 | EPHB1 | 1.81387854 |
| 13 | FGFR4 | 1.81260333 |
| 14 | FRK | 1.77200297 |
| 15 | PTK6 | 1.74707654 |
| 16 | CAMK1D | 1.74276188 |
| 17 | FGFR2 | 1.73010509 |
| 18 | PDGFRA | 1.70770390 |
| 19 | CAMK1G | 1.65419187 |
| 20 | PIK3CG | 1.63777532 |
| 21 | MAP3K10 | 1.59905975 |
| 22 | MAP3K13 | 1.59209260 |
| 23 | EEF2K | 1.56264495 |
| 24 | MAP3K11 | 1.55567587 |
| 25 | BCKDK | 1.54046578 |
| 26 | JAK1 | 1.43388462 |
| 27 | TTN | 1.42558214 |
| 28 | TESK1 | 1.41431845 |
| 29 | WNK4 | 1.38883976 |
| 30 | TNK2 | 1.34974316 |
| 31 | MAP3K7 | 1.33847839 |
| 32 | LATS1 | 1.29396500 |
| 33 | CDC42BPA | 1.29237106 |
| 34 | FGFR3 | 1.28854947 |
| 35 | LRRK2 | 1.27874839 |
| 36 | TAOK3 | 1.25744385 |
| 37 | RIPK4 | 1.22739582 |
| 38 | TAOK1 | 1.19120654 |
| 39 | PRKCH | 1.17794099 |
| 40 | PDGFRB | 1.16428546 |
| 41 | TAOK2 | 1.14540097 |
| 42 | TYK2 | 1.14514067 |
| 43 | PRKD1 | 1.05935216 |
| 44 | DDR2 | 1.03128205 |
| 45 | EPHA3 | 1.02661701 |
| 46 | FES | 1.01393713 |
| 47 | MAP3K2 | 1.01126903 |
| 48 | RET | 1.00872652 |
| 49 | MYLK | 1.00117430 |
| 50 | TBK1 | 0.98296170 |
| 51 | CDK12 | 0.97948589 |
| 52 | PIK3CA | 0.97225101 |
| 53 | GRK6 | 0.96633656 |
| 54 | KSR2 | 0.96321355 |
| 55 | PRKD2 | 0.96270933 |
| 56 | SIK2 | 0.95075301 |
| 57 | SGK3 | 0.95053441 |
| 58 | MAP4K1 | 0.94238822 |
| 59 | DMPK | 0.93695940 |
| 60 | EPHB2 | 0.92985603 |
| 61 | ITK | 0.92524340 |
| 62 | FLT3 | 0.89528455 |
| 63 | HIPK2 | 0.89309552 |
| 64 | MAP3K6 | 0.85582804 |
| 65 | JAK2 | 0.85547827 |
| 66 | MST1R | 0.85508016 |
| 67 | CSK | 0.85020990 |
| 68 | RPS6KC1 | 0.84549686 |
| 69 | RPS6KL1 | 0.84549686 |
| 70 | ARAF | 0.83972671 |
| 71 | STK39 | 0.82935084 |
| 72 | TYRO3 | 0.81998379 |
| 73 | DYRK1B | 0.81980254 |
| 74 | MTOR | 0.81703736 |
| 75 | STK38 | 0.78964762 |
| 76 | FER | 0.78774716 |
| 77 | KIT | 0.78235059 |
| 78 | ZAP70 | 0.77975938 |
| 79 | LMTK2 | 0.77383307 |
| 80 | IRAK3 | 0.77060378 |
| 81 | PRKD3 | 0.76566164 |
| 82 | PTK2 | 0.74364466 |
| 83 | BLK | 0.74165042 |
| 84 | PDK1 | 0.73938911 |
| 85 | CDK9 | 0.72813008 |
| 86 | MAP2K3 | 0.71613083 |
| 87 | KDR | 0.70354648 |
| 88 | PRKAA2 | 0.68011066 |
| 89 | TRPM7 | 0.66979112 |
| 90 | WNK1 | 0.65611071 |
| 91 | SIK3 | 0.64552162 |
| 92 | MAPK7 | 0.64114493 |
| 93 | RPS6KA6 | 0.63876860 |
| 94 | MAP3K3 | 0.63833157 |
| 95 | BTK | 0.63233040 |
| 96 | MARK2 | 0.63161408 |
| 97 | STK10 | 0.63118519 |
| 98 | MAPK12 | 0.62056033 |
| 99 | NEK9 | 0.62046882 |
| 100 | RPS6KA2 | 0.60606195 |
| 101 | PAK6 | 0.60518898 |
| 102 | PTK2B | 0.60511430 |
| 103 | CSF1R | 0.59899738 |
| 104 | MET | 0.59112380 |
| 105 | SGK2 | 0.58065885 |
| 106 | CAMKK2 | 0.57298746 |
| 107 | GSK3A | 0.54921136 |
| 108 | ILK | 0.54591262 |
| 109 | MAPK11 | 0.54069904 |
| 110 | PAK2 | 0.53775384 |
| 111 | PAK4 | 0.53528042 |
| 112 | MAPK4 | 0.52991693 |
| 113 | CAMKK1 | 0.52756948 |
| 114 | IGF1R | 0.52721401 |
| 115 | ROCK1 | 0.52247667 |
| 116 | PHKG1 | 0.52243321 |
| 117 | PHKG2 | 0.52243321 |
| 118 | TGFBR1 | 0.51730857 |
| 119 | MAP3K1 | 0.51389936 |
| 120 | IRAK2 | 0.50680687 |
| 121 | EPHA2 | 0.49870690 |
| 122 | IRAK4 | 0.49851074 |
| 123 | PAK3 | 0.49795170 |
| 124 | UHMK1 | 0.49227268 |
| 125 | JAK3 | 0.48761742 |
| 126 | TESK2 | 0.48570525 |
| 127 | NTRK1 | 0.48344418 |
| 128 | PDPK1 | 0.47988582 |
| 129 | NLK | 0.47682587 |
| 130 | PRKG2 | 0.46865447 |
| 131 | BMX | 0.46122077 |
| 132 | MAPK15 | 0.46090650 |
| 133 | CDK6 | 0.45991889 |
| 134 | SGK223 | 0.45672020 |
| 135 | SGK494 | 0.45672020 |
| 136 | HCK | 0.45297275 |
| 137 | MAP2K2 | 0.43482231 |
| 138 | MAPKAPK3 | 0.42898387 |
| 139 | PIM2 | 0.39957528 |
| 140 | NME2 | 0.39358344 |
| 141 | FYN | 0.38746326 |
| 142 | MAP3K14 | 0.38579358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.28230070 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.08257194 |
| 3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90254379 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.86976480 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.82185314 |
| 6 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.73505187 |
| 7 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.68580765 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.64115576 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59564384 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.54886638 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.51047756 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.50096818 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46656969 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.44431008 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.42952102 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36128218 |
| 17 | Insulin resistance_Homo sapiens_hsa04931 | 1.32407491 |
| 18 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.28969643 |
| 19 | ABC transporters_Homo sapiens_hsa02010 | 1.28400571 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.27015901 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26593102 |
| 22 | Prion diseases_Homo sapiens_hsa05020 | 1.24302943 |
| 23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.24143228 |
| 24 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.21836124 |
| 25 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.21706580 |
| 26 | Focal adhesion_Homo sapiens_hsa04510 | 1.17688693 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16654252 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15015014 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.13504806 |
| 30 | Lysine degradation_Homo sapiens_hsa00310 | 1.12659350 |
| 31 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.11707588 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10343346 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.09340542 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.08005202 |
| 35 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07298639 |
| 36 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.06611609 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06413189 |
| 38 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05279906 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04237251 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.02932990 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02481346 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.01716077 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01276394 |
| 44 | Endocytosis_Homo sapiens_hsa04144 | 1.00482160 |
| 45 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00060237 |
| 46 | Long-term potentiation_Homo sapiens_hsa04720 | 0.99991870 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98579600 |
| 48 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.98182237 |
| 49 | Leishmaniasis_Homo sapiens_hsa05140 | 0.97845460 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.97667357 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97277715 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96725288 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.96065388 |
| 54 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92879412 |
| 55 | Malaria_Homo sapiens_hsa05144 | 0.92871112 |
| 56 | Bladder cancer_Homo sapiens_hsa05219 | 0.91691479 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91303609 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90805314 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.89233803 |
| 60 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.87156610 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85333686 |
| 62 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84649942 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 0.82969179 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 0.82648451 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81501819 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81113710 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80051088 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79785644 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 0.79664237 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79268657 |
| 71 | Histidine metabolism_Homo sapiens_hsa00340 | 0.79059570 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.78357578 |
| 73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77734822 |
| 74 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77181664 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77123757 |
| 76 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.76356160 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75850855 |
| 78 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75151988 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74632925 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74165426 |
| 81 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.73708488 |
| 82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73644822 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72488250 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72473839 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71772179 |
| 86 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71605873 |
| 87 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.71319319 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.70699864 |
| 89 | Melanogenesis_Homo sapiens_hsa04916 | 0.70015448 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69764408 |
| 91 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69427808 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69287485 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.69231890 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68863019 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68527438 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.67211566 |
| 97 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.66956323 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66472660 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66404414 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66207120 |
| 101 | Hepatitis B_Homo sapiens_hsa05161 | 0.65740656 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65247884 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65124063 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64301812 |
| 105 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.63987074 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63789369 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63376355 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.63297940 |
| 109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62386601 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62045084 |
| 111 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61727322 |
| 112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61713026 |
| 113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.61540575 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61016613 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60950963 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.59551018 |
| 117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59531592 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59235194 |
| 119 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.59185136 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.58548271 |
| 121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58526861 |
| 122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58338361 |
| 123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57952810 |
| 124 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57490692 |
| 125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57274135 |
| 126 | Cocaine addiction_Homo sapiens_hsa05030 | 0.56808692 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56690910 |
| 128 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56675210 |
| 129 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56656691 |
| 130 | Axon guidance_Homo sapiens_hsa04360 | 0.56211549 |
| 131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55946442 |
| 132 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.55495323 |
| 133 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55454721 |
| 134 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55066124 |
| 135 | Apoptosis_Homo sapiens_hsa04210 | 0.54878756 |
| 136 | Influenza A_Homo sapiens_hsa05164 | 0.54227243 |
| 137 | Glioma_Homo sapiens_hsa05214 | 0.53132153 |
| 138 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52862836 |
| 139 | Prostate cancer_Homo sapiens_hsa05215 | 0.52625281 |
| 140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52123263 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50723093 |
| 142 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50351715 |
| 143 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49565061 |
| 144 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48539212 |
| 145 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47936077 |
| 146 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.47635204 |
| 147 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47518412 |
| 148 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46731775 |
| 149 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46148044 |
| 150 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45985205 |
| 151 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45716931 |
| 152 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45332619 |
| 153 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45166954 |
| 154 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44598024 |
| 155 | Insulin secretion_Homo sapiens_hsa04911 | 0.43822808 |

